Marinus Pharmaceuticals marinuspharma.com


Public list: BIO 2016 (619) Pharma Startups (4732) Rare Diseases (230)

Marinus Pharmaceuticals is a privately held specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of ganaxolone to treat serious neurological and psychiatric disorders. Ganaxolone is the most advanced neurosteroid in development for Epilepsy, Posttraumatic Stress Disorder and Fragile-X Syndrome. Marinus has completed a successful Phase 2 trial with ganaxolone in adult partial onset seizures, and a Phase 2 proof of concept PTSD study has initiated wit...Show all

Marinus Pharmaceuticals is a privately held specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of ganaxolone to treat serious neurological and psychiatric disorders. Ganaxolone is the most advanced neu...Show all

Company (IPO / Went public)

Phone: 484-801-4674

Fax:

100 Matsonford Road Suite 304

Wayne, 19087
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Marinus Pharmaceuticals $118.4M Jul 31, 2014
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Marinus Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors

Competitors

Company Status Description Investors
See all 15 competitors